K260479 is an FDA 510(k) clearance for the TheraSphere 360™ Y-90 Management Platform. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).
Submitted by Boston Scientific Corporation (Marborough, US). The FDA issued a Cleared decision on March 13, 2026, 28 days after receiving the submission on February 13, 2026.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.
| 510(k) Number | K260479 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | February 13, 2026 |
| Decision Date | March 13, 2026 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | LLZ — System, Image Processing, Radiological |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 892.2050 |